LAVA Therapeutics NV
NASDAQ:LVTX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.48
4.03
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
LAVA Therapeutics NV
LAVA Therapeutics NV
Total Current Liabilities
LAVA Therapeutics NV
Total Current Liabilities Peer Comparison
PHARM
PRQR
QURE
ARGX
MRUS
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
LAVA Therapeutics NV
NASDAQ:LVTX
|
Total Current Liabilities
$14.9m
|
CAGR 3-Years
27%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pharming Group NV
AEX:PHARM
|
Total Current Liabilities
$78m
|
CAGR 3-Years
24%
|
CAGR 5-Years
3%
|
CAGR 10-Years
17%
|
|
|
ProQR Therapeutics NV
NASDAQ:PRQR
|
Total Current Liabilities
€37.3m
|
CAGR 3-Years
44%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
Uniqure NV
NASDAQ:QURE
|
Total Current Liabilities
$71.3m
|
CAGR 3-Years
19%
|
CAGR 5-Years
20%
|
CAGR 10-Years
18%
|
|
|
argenx SE
XBRU:ARGX
|
Total Current Liabilities
$499.6m
|
CAGR 3-Years
27%
|
CAGR 5-Years
37%
|
CAGR 10-Years
69%
|
|
|
Merus NV
NASDAQ:MRUS
|
Total Current Liabilities
$80.1m
|
CAGR 3-Years
4%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
See Also
What is LAVA Therapeutics NV's Total Current Liabilities?
Total Current Liabilities
14.9m
USD
Based on the financial report for Dec 31, 2023, LAVA Therapeutics NV's Total Current Liabilities amounts to 14.9m USD.
What is LAVA Therapeutics NV's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 3Y
27%
Over the last year, the Total Current Liabilities growth was -32%. The average annual Total Current Liabilities growth rates for LAVA Therapeutics NV have been 27% over the past three years .
You don't have any saved screeners yet
